The Prostate Health Index in predicting initial prostate biopsy outcomes in Asian men with prostate-specific antigen levels of 4-10 ng/mL. (Q38394519)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24136184%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

title

The Prostate Health Index in predicting initial prostate biopsy outcomes in Asian men with prostate-specific antigen levels of 4-10 ng/mL (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24136184%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24136184%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Kim W M Lee

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24136184%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

author name string

Peter K F Chiu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24136184%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

N Y Lam

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24136184%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

H C Lam

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24136184%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Simon S M Hou

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24136184%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

publication date

18 October 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24136184%20AND%20SRC:MED&resulttype=core&format=json

International Urology and Nephrology

28 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24136184%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24136184%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24136184%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

711-717

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24136184%20AND%20SRC:MED&resulttype=core&format=json

Changing demography of prostate cancer in Asia

28 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0582-0

Prostate-specific antigen screening: pro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0582-0

Morbidity of prostate biopsy after simplified versus complex preparation protocols: assessment of risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0582-0

Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0582-0

PSA and beyond: the past, present, and future of investigative biomarkers for prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0582-0

Prostate-specific antigen (PSA) isoform p2PSA in combination with total PSA and free PSA improves diagnostic accuracy in prostate cancer detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0582-0

Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: results of a prospective study in a clinical setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0582-0

A multicenter study of [-2]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/ml prostate specific antigen range

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0582-0

Optimizing performance and interpretation of prostate biopsy: a critical analysis of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0582-0

Optimization of initial prostate biopsy in clinical practice: sampling, labeling and specimen processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0582-0

Pre-treatment risk stratification of prostate cancer patients: A critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0582-0

Diagnostic significance of [-2]pro-PSA and prostate dimension-adjusted PSA-related indices in men with total PSA in the 2.0-10.0 ng/mL range

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0582-0

Multicenter evaluation of [-2]proprostate-specific antigen and the prostate health index for detecting prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0582-0

Cost-effectiveness of Prostate Health Index for prostate cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0582-0

A multicenter evaluation of the PCA3 molecular urine test: pre-analytical effects, analytical performance, and diagnostic accuracy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0582-0

Performance of prostate cancer antigen 3 (PCA3) and prostate-specific antigen in Prescreened men: reproducibility and detection characteristics for prostate cancer patients with high PCA3 scores (≥ 100).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0582-0

Prostate cancer screening: clinical impact of WHO calibration of Beckman Coulter Access prostate-specific antigen assays

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24136184

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Evaluation of [-2] proPSA and Prostate Health Index (phi) for the detection of prostate cancer: a systematic review and meta-analysis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24136184

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Pre-analytical in-vitro stability of [-2]proPSA in blood and serum

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24136184